Elizabeth D. Barnett, MD
Professor
Boston University Chobanian & Avedisian School of Medicine
Dept of Pediatrics
Infectious Diseases

MD, Boston University



For more than 25 years at BUSM/BMC, Dr. Barnett has been a clinical and academic leader who has achieved international prominence in Travel and Tropical Medicine with a particular focus on refugee health and the medical needs of new immigrant families. She has served as the PI of the BMC Refugee Health Assessment Program for more than 20 years and also is Site Director for the GeoSentinel Program in partnership with the Centers for Disease Control. In addition, Dr. Barnett has studied the safety and dissemination of childhood immunizations and is a leader in the BMC Center for Immunization Safety and Assessment.

Nationally recognized for her work in Pediatric Infectious Diseases, Dr. Barnett is a member of the Committee on Infectious Diseases of the American Academy of Pediatrics, the body that publishes the Red Book, which is the authoritative text for the treatment of Pediatric Infectious Diseases. She has published more than 90 peer-reviewed manuscripts and presented at numerous national and international meetings and seminars.

Dr. Barnett completed her pediatric residency at Boston City Hospital (BCH) and Children’s Hospital, Boston. After serving as a Chief Resident in the Department of Pediatrics, she completed fellowship training in Pediatric Infectious Diseases at BCH under the direction of Drs. Pelton and Jerome Klein.


A Phase lll Randomized, Double-blind, Placebo-Controlled Three-Lot Consistency Study in Healthy Adult Volunteers to Assess Immunogenicity, and Clinical Acceptability of a Single-dose of the Live Oral
03/06/2014 - 03/05/2017 (PI)
PaxVax, Inc.


A Phase lll Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200
11/01/2013 - 10/31/2016 (PI)
PaxVax, Inc.


A Multicenter, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability pharmacokinetics an efficacy of ceftaroline versus cetriaxone in pediatric subjects with compli
01/01/2013 - 06/30/2015 (PI)
Cerexa, Inc.


A multi-center, randomized, observer-blinded, active-controlled study evaluating the safety, tolerability, pharmacokinetics and efficacy of ceftaroline versus cetriaxone plus vancomycin in pediatric
10/01/2012 - 09/30/2013 (PI)
Cerexa, Inc.


Long Term Immunity and Safety following Vaccination with the Japanese Ecephalitis Vaccine IC51 in a Pediatric Population in Non-endemic Countries
12/12/2011 - 12/11/2012 (PI)
Intercell AG


IMMUNOGENICITY AND SAFETY OF THE JAPANESE ENCEPHALITIS VACCINE IC51 (IXIARO, JESPECT) IN A PEDIATRIC POPULATION IN NON-ENDEMIC COUNTRIES. UNCONTROLLED, OPEN-LABEL PHASE 3 STUDY
02/01/2010 - 06/30/2012 (PI)
Intercell AG


Evaluation of Impact of Antimicrobial Therapy on Carriage of Susceptible and Resistant Streptococcus Pneumoniae
09/01/1999 - 06/30/2004 (PI)
SmithKline Beecham

Use of Intrapulmonary Percussive Ventilation to Prevent Respiratory Disease in Adolescents with Impaired Pulmonary Function
09/01/1999 - 08/31/2000 (PI)
Deborah Munroe Noonan Memorial Fund Medical Fdn Inc


A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSE(S) OF
07/06/2021 - 07/06/2024 (PI)
Pfizer, Inc

A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBO-CONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALT
03/08/2021 - 03/08/2024 (PI)
Pfizer, Inc

Refugee And Immigrant Health P
01/01/1992 - 06/30/2023 (PI)
DPH DHHS

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY OF A 20-VALENT…
06/29/2020 - 06/28/2023 (PI)
Pfizer, Inc

A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND, DOSE-FINDING STUDY…
05/29/2020 - 05/28/2023 (PI)
Pfizer, Inc

A Phase 3, Randomized, Double- or Observer-Blinded, Placebo Controlled Trial to Evaluate the…
03/09/2020 - 03/09/2023 (PI)
Pfizer, Inc

Clinical Immunization Safety Assessment (CISA) Project - Cli
09/29/2016 - 10/28/2022 (PI)
Centers for Disease Control and Prevention/DHHS

ThreeWire BAA/Secondment Agreement
10/07/2019 - 10/06/2022 (PI)
ThreeWire Inc.

A PHASE 2b, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY…
08/22/2019 - 08/21/2022 (PI)
Pfizer, Inc

CISA COVID
09/17/2020 - 03/31/2022 (PI)
CDC

Showing 10 of 15 results. Show All Results

Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Belay ED, Godfred Cato S, Rao AK, Abrams J, Wyatt Wilson W, Lim S, Newton-Cheh C, Melgar M, DeCuir J, Webb B, Marquez P, Su JR, Meng L, Grome HN, Schlaudecker E, Talaat K, Edwards K, Barnett E, Campbell AP, Broder KR, Bamrah Morris S. Multisystem Inflammatory Syndrome in Adults After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Coronavirus Disease 2019 (COVID-19) Vaccination. Clin Infect Dis. 2022 Aug 24; 75(1):e741-e748. PMID: 34849680; PMCID: PMC8690151; DOI: 10.1093/cid/ciab936;
     
  2. Taglauer ES, Dhole Y, Boateng J, Snyder-Cappione J, Parker SE, Clarke K, Juttukonda L, Devera J, Hunnewell J, Barnett E, Jia H, Yarrington C, Sabharwal V, Wachman EM. Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation. J Perinatol. 2022 Oct; 42(10):1319-1327.View Related Profiles. PMID: 35449446; PMCID: PMC9022897; DOI: 10.1038/s41372-022-01391-9;
     
  3. Balogun O, Brown A, Angelo KM, Hochberg NS, Barnett ED, Nicolini LA, Asgeirsson H, Grobusch MP, Leder K, Salvador F, Chen L, Odolini S, Díaz-Menéndez M, Gobbi F, Connor BA, Libman M, Hamer DH. Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020. J Travel Med. 2022 03 21; 29(2).View Related Profiles. PMID: 35134210; PMCID: PMC9383360; DOI: 10.1093/jtm/taac013;
     
  4. Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, Edwards K, Soslow JH, Dendy JM, Schlaudecker E, Lang SM, Barnett ED, Ruberg FL, Smith MJ, Campbell MJ, Lopes RD, Sperling LS, Baumblatt JA, Thompson DL, Marquez PL, Strid P, Woo J, Pugsley R, Reagan-Steiner S, DeStefano F, Shimabukuro TT. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA. 2022 01 25; 327(4):331-340.View Related Profiles. PMID: 35076665; PMCID: PMC8790664; DOI: 10.1001/jama.2021.24110;
     
  5. Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Sahin U, Jansen KU, Gruber WC. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2022 01 06; 386(1):35-46. PMID: 34752019; PMCID: PMC8609605; DOI: 10.1056/NEJMoa2116298;
     
  6. Boateng JO, Wachman EM, Turcinovic J, Devera J, Jain M, Jean-Sicard S, Woodard E, Cruikshank A, Sinha B, Bartolome R, Barnett ED, Parker MG, Yarrington C, Connor JH, Taglauer E, Sabharwal V. SARS-CoV-2 in infant urine and fecal samples after in utero COVID-19 exposure. Pediatr Res. 2022 Aug; 92(2):536-540.View Related Profiles. PMID: 34718351; PMCID: PMC8556813; DOI: 10.1038/s41390-021-01822-x;
     
  7. Eimer J, Patimeteeporn C, Jensenius M, Gkrania-Klotsas E, Duvignaud A, Barnett ED, Hochberg NS, Chen LH, Trigo-Esteban E, Gertler M, Greenaway C, Grobusch MP, Angelo KM, Hamer DH, Caumes E, Asgeirsson H. Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020. J Travel Med. 2021 08 27; 28(6).View Related Profiles. PMID: 33987682; PMCID: PMC9638878; DOI: 10.1093/jtm/taab069;
     
  8. Aggarwal A, Cohen E, Figueira M, Sabharwal V, Herlihy JM, Bronwen C, Barnett ED, Pelton SI, Camelo IY. Multisystem Inflammatory Syndrome in an Adult With COVID-19-A Trial of Anakinra: A Case Report. Infect Dis Clin Pract (Baltim Md). 2021 Nov; 29(6):e420-e423.View Related Profiles. PMID: 34803350; PMCID: PMC8594393; DOI: 10.1097/IPC.0000000000001028;
     
  9. Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746.View Related Profiles. PMID: 33853145
     
  10. Schmader KE, Liu CK, Harrington T, Rountree W, Auerbach H, Walter EB, Barnett ED, Schlaudecker EP, Todd CA, Poniewierski M, Staat MA, Wodi P, Broder KR. Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2021 01 04; 4(1):e2031266. PMID: 33443580; PMCID: PMC7809592; DOI: 10.1001/jamanetworkopen.2020.31266;
     
Showing 10 of 110 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 110 publications over 31 distinct years, with a maximum of 11 publications in 2013

YearPublications
19911
19923
19931
19943
19952
19961
19972
19982
19992
20004
20011
20022
20034
20043
20054
20073
20083
20092
20106
20112
20127
201311
20144
20153
20164
20178
20186
20194
20202
20216
20224
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Travel and Tropical Medicine
refugee health
immigrant health
Pediatric Infectious Diseases
Contact for Mentoring:

774 Albany St
Boston MA 02118
Google Map


Barnett's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department